WORK to Save Lives Act

S. 3812 would direct the Secretary of Labor to develop and issue guidance and regulations regarding opioid overdose reversal medication, commonly known as naloxone or Narcan, and related employee training requirements. The bill aims to address workplace safety by establishing standards for how employers should handle opioid overdose emergencies among their workers.

If enacted, this legislation could require employers to stock overdose reversal medication in workplaces and train employees on its use, similar to how many workplaces maintain automated external defibrillators (AEDs) for cardiac emergencies. This would potentially expand access to life-saving medication in work environments and ensure employees know how to respond to overdose situations. The bill is currently under consideration by the Senate Committee on Health, Education, Labor, and Pensions, which held hearings on it in March 2026.